A glance at subgenomic flavivirus RNAs and microRNAs in flavivirus infections

Virology Journal

Volumn 13, Issue 1, 2016, Pages

  Bavia, Lorena ^a   Mosimann, Ana Luiza Pamplona ^a   Aoki, Mateus Nóbrega ^a   Duarte Dos Santos, Claudia Nunes ^a  

^a INSTITUTO CARLOS CHAGAS   (Brazil)

Author keywords

Flavivirus; MicroRNAs; Subgenomic flavivirus RNAs; Untranslated region; Viral replication

Indexed keywords

MESSENGER RNA; MICRORNA; SINGLE STRANDED RNA; SUBGENOMIC FLAVIVIRUS RNA; UNCLASSIFIED DRUG; VIRUS RNA;

3' UNTRANSLATED REGION; ARTICLE; BIOGENESIS; CELLULAR IMMUNITY; DENGUE; DENGUE VIRUS; EUKARYOTIC CELL; FLAVIVIRUS; FLAVIVIRUS INFECTION; HOST CELL; HUMAN; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; LIFE CYCLE; MURRAY VALLEY ENCEPHALITIS; MURRAY VALLEY ENCEPHALITIS VIRUS; NONHUMAN; RNA ANALYSIS; RNA DEGRADATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; WEST NILE FEVER; WEST NILE VIRUS; YELLOW FEVER; YELLOW FEVER VIRUS; ANIMAL; FLAVIVIRIDAE; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALS; FLAVIVIRIDAE; FLAVIVIRUS INFECTIONS; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; MICRORNAS; RNA, VIRAL; VIRUS REPLICATION;

EID: 85049564778     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/s12985-016-0541-3     Document Type: Article

References (140)

1. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75(5): 843-54.
2. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000; 403(6772): 901-6.
3. Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature. 2000; 408(6808): 86-9.
4. Dogini DB, Pascoal VD, Avansini SH, Vieira AS, Pereira TC, Lopes-Cendes I. The new world of RNAs. Genet Mol Biol. 2014; 37(1 Suppl): 285-93.
5. Browse miRBase by species. http://www. mirbase. org/cgi-bin/browse. pl?org=hsa. Accessed 11 May 2016.
6. Friedlander MR, Lizano E, Houben AJ, Bezdan D, Banez-Coronel M, Kudla G, et al. Evidence for the biogenesis of more than 1, 000 novel human microRNAs. Genome Biol. 2014; 15(4): R57.
7. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009; 10(2): 126-39.
8. Ozsolak F, Poling LL, Wang Z, Liu H, Liu XS, Roeder RG, et al. Chromatin structure analyses identify miRNA promoters. Genes Dev. 2008; 22(22): 3172-83.
9. Monteys AM, Spengler RM, Wan J, Tecedor L, Lennox KA, Xing Y, et al. Structure and activity of putative intronic miRNA promoters. RNA. 2010; 16(3): 495-505.
10. Tal TL, Tanguay RL. Non-coding RNAs-novel targets in neurotoxicity. Neurotoxicology. 2012; 33(3): 530-44.
11. miRBase: the microRNA database. http://www. mirbase. org/. Accessed 11 May 2016.
12. Grundhoff A, Sullivan CS. Virus-encoded microRNAs. Virology. 2011; 411(2): 325-43.
13. Pfeffer S, Zavolan M, Grässer FA, Chien M, Russo JJ, Ju J, et al. Identification of virus-encoded microRNAs. Science. 2004; 304(5671): 734-6.
14. Klase Z, Kale P, Winograd R, Gupta MV, Heydarian M, Berro R, et al. HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol Biol. 2007; 8: 63.
15. Hussain M, Torres S, Schnettler E, Funk A, Grundhoff A, Pijlman GP, et al. West Nile virus encodes a microRNA-like small RNA in the 3 untranslated region which up-regulates GATA4 mRNA and facilitates virus replication in mosquito cells. Nucleic Acids Res. 2012; 40(5): 2210-23.
16. Hussain M, Asgari S. MicroRNA-like viral small RNA from Dengue virus 2 autoregulates its replication in mosquito cells. Proc Natl Acad Sci U S A. 2014; 111(7): 2746-51.
17. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004; 23(20): 4051-60.
18. Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 2002; 21(17): 4663-70.
19. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, et al. The Microprocessor complex mediates the genesis of microRNAs. Nature. 2004; 432(7014): 235-40.
20. Kim YK, Kim VN. Processing of intronic microRNAs. EMBO J. 2007; 26(3): 775-83.
21. Pawlicki JM, Steitz JA. Primary microRNA transcript retention at sites of transcription leads to enhanced microRNA production. J Cell Biol. 2008; 182(1): 61-76.
22. Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee JK, et al. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell. 2006; 125(5): 887-901.
23. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003; 425(6956): 415-9.
24. Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the Microprocessor complex. Nature. 2004; 432(7014): 231-5.
25. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003; 17(24): 3011-6.
26. Kawamata T, Tomari Y. Making RISC. Trends Biochem Sci. 2010; 35(7): 368-76.
27. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science. 2004; 305(5689): 1437-41.
28. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136(2): 215-33.
29. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell. 2003; 115(7): 787-98.
30. Rigoutsos I. New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites. Cancer Res. 2009; 69(8): 3245-8.
31. Abdelfattah AM, Park C, Choi MY. Update on non-canonical microRNAs. Biomol Concepts. 2014; 5(4): 275-87.
32. Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014; 15(8): 509-24.
33. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2): 281-97.
34. Hammond SM. Dicing and slicing: the core machinery of the RNA interference pathway. FEBS Lett. 2005; 579(26): 5822-9.
35. Lee YS, Nakahara K, Pham JW, Kim K, He Z, Sontheimer EJ, et al. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell. 2004; 117(1): 69-81.
36. Brackney DE, Scott JC, Sagawa F, Woodward JE, Miller NA, Schilkey FD, et al. C6/36 Aedes albopictus cells have a dysfunctional antiviral RNA interference response. PLoS Negl Trop Dis. 2010; 4(10): e856.
37. Vidigal JA, Ventura A. The biological functions of miRNAs: lessons from in vivo studies. Trends Cell Biol. 2015; 25(3): 137-47.
38. Eiring AM, Harb JG, Neviani P, Garton C, Oaks JJ, Spizzo R, et al. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell. 2010; 140(5): 652-65.
39. Li M, Marin-Muller C, Bharadwaj U, Chow KH, Yao Q, Chen C. MicroRNAs: control and loss of control in human physiology and disease. World J Surg. 2009; 33(4): 667-84.
40. Mu P, Han YC, Betel D, Yao E, Squatrito M, Ogrodowski P, et al. Genetic dissection of the miR-17 ~ 92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 2009; 23(24): 2806-11.
41. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 2009; 23(24): 2839-49.
42. Abd-El-Fattah AA, Sadik NA, Shaker OG, Aboulftouh ML. Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia. Cell Biochem Biophys. 2013; 67(3): 875-84.
43. Akamatsu S, Hayes CN, Tsuge M, Miki D, Akiyama R, Abe H, et al. Differences in serum microRNA profiles in hepatitis B and C virus infection. J Infect. 2015; 70(3): 273-87.
44. Heneghan HM, Miller N, Kelly R, Newell J, Kerin MJ. Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist. 2010; 15(7): 673-82.
45. Anokye-Danso F, Snitow M, Morrisey EE. How microRNAs facilitate reprogramming to pluripotency. J Cell Sci. 2012; 125(Pt 18): 4179-87.
46. Card DA, Hebbar PB, Li L, Trotter KW, Komatsu Y, Mishina Y, et al. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol. 2008; 28(20): 6426-38.
47. Cheloufi S, Dos Santos CO, Chong MM, Hannon GJ. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature. 2010; 465(7298): 584-9.
48. Zhang X, Wang H, Zhang S, Song J, Zhang Y, Wei X, et al. MiR-134 functions as a regulator of cell proliferation, apoptosis, and migration involving lung septation. In Vitro Cell Dev Biol Anim. 2012; 48(2): 131-6.
49. Guo L, Xu J, Qi J, Zhang L, Wang J, Liang J, et al. MicroRNA-17-92a upregulation by estrogen leads to Bim targeting and inhibition of osteoblast apoptosis. J Cell Sci. 2013; 126(Pt 4): 978-88.
50. Mondanizadeh M, Arefian E, Mosayebi G, Saidijam M, Khansarinejad B, Hashemi SM. MicroRNA-124 Regulates Neuronal Differentiation of Mesenchymal Stem Cells by Targeting Sp1 mRNA. J Cell Biochem. 2015; 116(6): 943-53.
51. Esguerra JL, Mollet IG, Salunkhe VA, Wendt A, Eliasson L. Regulation of pancreatic beta cell stimulus-secretion coupling by microRNAs. Genes (Basel). 2014; 5(4): 1018-31.
52. Vickers KC, Landstreet SR, Levin MG, Shoucri BM, Toth CL, Taylor RC, et al. MicroRNA-223 coordinates cholesterol homeostasis. Proc Natl Acad Sci U S A. 2014; 111(40): 14518-23.
53. Allantaz F, Cheng DT, Bergauer T, Ravindran P, Rossier MF, Ebeling M, et al. Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. PLoS One. 2012; 7(1): e29979.
54. Nukui M, Mori Y, Murphy EA. A human herpesvirus 6A-encoded microRNA: role in viral lytic replication. J Virol. 2015; 89(5): 2615-27.
55. Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A. 2012; 109(31): E2110-6.
56. Boss IW, Renne R. Viral miRNAs and immune evasion. Biochim Biophys Acta. 2011; 1809(11-12): 708-14.
57. Fa M. Togavirus morphology and morphogenesis. In: Schlesinger R, editor. The togaviruses: biology, structure, replication. New York: Academic; 1980. p. 241-316.
58. Chambers TJ, Hahn CS, Galler R, Rice CM. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol. 1990; 44: 649-88.
59. Brinton MA, Basu M. Functions of the 3 and 5 genome RNA regions of members of the genus Flavivirus. Virus Res. 2015; 206: 108-19.
60. Cahour A, Pletnev A, Vazielle-Falcoz M, Rosen L, Lai CJ. Growth-restricted dengue virus mutants containing deletions in the 5 noncoding region of the RNA genome. Virology. 1995; 207(1): 68-76.
61. Proutski V, Gritsun TS, Gould EA, Holmes EC. Biological consequences of deletions within the 3untranslated region of flaviviruses may be due to rearrangements of RNA secondary structure. Virus Res. 1999; 64(2): 107-23.
62. Cui T, Sugrue RJ, Xu Q, Lee AK, Chan YC, Fu J. Recombinant dengue virus type 1 NS3 protein exhibits specific viral RNA binding and NTPase activity regulated by the NS5 protein. Virology. 1998; 246(2): 409-17.
63. Shi PY, Li W, Brinton MA. Cell proteins bind specifically to West Nile virus minus-strand 3 stem-loop RNA. J Virol. 1996; 70(9): 6278-87.
64. Hahn CS, Hahn YS, Rice CM, Lee E, Dalgarno L, Strauss EG, et al. Conserved elements in the 3 untranslated region of flavivirus RNAs and potential cyclization sequences. J Mol Biol. 1987; 198(1): 33-41.
65. Proutski V, Gould EA, Holmes EC. Secondary structure of the 3 untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res. 1997; 25(6): 1194-202.
66. Olsthoorn RC, Bol JF. Sequence comparison and secondary structure analysis of the 3 noncoding region of flavivirus genomes reveals multiple pseudoknots. RNA. 2001; 7(10): 1370-7.
67. Gritsun TS, Gould EA. Direct repeats in the 3 untranslated regions of mosquito-borne flaviviruses: possible implications for virus transmission. J Gen Virol. 2006; 87(Pt 11): 3297-305.
68. Rice CM, Lenches EM, Eddy SR, Shin SJ, Sheets RL, Strauss JH. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science. 1985; 229(4715): 726-33.
69. Rouha H, Thurner C, Mandl CW. Functional microRNA generated from a cytoplasmic RNA virus. Nucleic Acids Res. 2010; 38(22): 8328-37.
70. Shapiro JS, Langlois RA, Pham AM, Tenoever BR. Evidence for a cytoplasmic microprocessor of pri-miRNAs. RNA. 2012; 18(7): 1338-46.
71. Gaglia MM, Glaunsinger BA. Viruses and the cellular RNA decay machinery. Wiley Interdiscip Rev RNA. 2010; 1(1): 47-59.
72. Moon SL, Barnhart MD, Wilusz J. Inhibition and avoidance of mRNA degradation by RNA viruses. Curr Opin Microbiol. 2012; 15(4): 500-5.
73. Moon SL, Wilusz J. Cytoplasmic viruses: rage against the (cellular RNA decay) machine. PLoS Pathog. 2013; 9(12): e1003762.
74. Green AM, Beatty PR, Hadjilaou A, Harris E. Innate immunity to dengue virus infection and subversion of antiviral responses. J Mol Biol. 2014; 426(6): 1148-60.
75. Roby JA, Pijlman GP, Wilusz J, Khromykh AA. Noncoding subgenomic flavivirus RNA: multiple functions in West Nile virus pathogenesis and modulation of host responses. Viruses. 2014; 6(2): 404-27.
76. Moon SL, Anderson JR, Kumagai Y, Wilusz CJ, Akira S, Khromykh AA, et al. A noncoding RNA produced by arthropod-borne flaviviruses inhibits the cellular exoribonuclease XRN1 and alters host mRNA stability. RNA. 2012; 18(11): 2029-40.
77. Charley PA, Wilusz J. Standing your ground to exoribonucleases: Function of Flavivirus long non-coding RNAs. Virus Res. 2015; 212: 70-7.
78. Moon SL, Dodd BJ, Brackney DE, Wilusz CJ, Ebel GD, Wilusz J. Flavivirus sfRNA suppresses antiviral RNA interference in cultured cells and mosquitoes and directly interacts with the RNAi machinery. Virology. 2015; 485: 322-9.
79. Urosevic N, van Maanen M, Mansfield JP, Mackenzie JS, Shellam GR. Molecular characterization of virus-specific RNA produced in the brains of flavivirus-susceptible and-resistant mice after challenge with Murray Valley encephalitis virus. J Gen Virol. 1997; 78(Pt 1): 23-9.
80. Lin KC, Chang HL, Chang RY. Accumulation of a 3-terminal genome fragment in Japanese encephalitis virus-infected mammalian and mosquito cells. J Virol. 2004; 78(10): 5133-8.
81. Scherbik SV, Paranjape JM, Stockman BM, Silverman RH, Brinton MA. RNase L plays a role in the antiviral response to West Nile virus. J Virol. 2006; 80(6): 2987-99.
82. Pijlman GP, Funk A, Kondratieva N, Leung J, Torres S, van der Aa L, et al. A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell Host Microbe. 2008; 4(6): 579-91.
83. Funk A, Truong K, Nagasaki T, Torres S, Floden N, Balmori Melian E, et al. RNA structures required for production of subgenomic flavivirus RNA. J Virol. 2010; 84(21): 11407-17.
84. Chapman EG, Moon SL, Wilusz J, Kieft JS. RNA structures that resist degradation by Xrn1 produce a pathogenic Dengue virus RNA. Elife. 2014; 3: e01892.
85. Chapman EG, Costantino DA, Rabe JL, Moon SL, Wilusz J, Nix JC, et al. The structural basis of pathogenic subgenomic flavivirus RNA (sfRNA) production. Science. 2014; 344(6181): 307-10.
86. Colpitts TM, Conway MJ, Montgomery RR, Fikrig E. West Nile Virus: biology, transmission, and human infection. Clin Microbiol Rev. 2012; 25(4): 635-48.
87. Schuessler A, Funk A, Lazear HM, Cooper DA, Torres S, Daffis S, et al. West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response. J Virol. 2012; 86(10): 5708-18.
88. Schnettler E, Sterken MG, Leung JY, Metz SW, Geertsema C, Goldbach RW, et al. Noncoding flavivirus RNA displays RNA interference suppressor activity in insect and Mammalian cells. J Virol. 2012; 86(24): 13486-500.
89. Parameswaran P, Sklan E, Wilkins C, Burgon T, Samuel MA, Lu R, et al. Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog. 2010; 6(2): e1000764.
90. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al. Dengue: A continuing global threat. Nat Rev Microbiol. 2010; 8(12 Suppl): S7-16.
91. Liu R, Yue L, Li X, Yu X, Zhao H, Jiang Z, et al. Identification and characterization of small sub-genomic RNAs in dengue 1-4 virusinfected cell cultures and tissues. Biochem Biophys Res Commun. 2010; 391(1): 1099-103.
92. Liu Y, Liu H, Zou J, Zhang B, Yuan Z. Dengue virus subgenomic RNA induces apoptosis through the Bcl-2-mediated PI3k/Akt signaling pathway. Virology. 2014; 448: 15-25.
93. Bidet K, Dadlani D, Garcia-Blanco MA. G3BP1, G3BP2 and CAPRIN1 are required for translation of interferon stimulated mRNAs and are targeted by a dengue virus non-coding RNA. PLoS Pathog. 2014; 10(7): e1004242.
94. Bidet K, Garcia-Blanco MA. Flaviviral RNAs: weapons and targets in the war between virus and host. Biochem J. 2014; 462(2): 215-30.
95. Manokaran G, Finol E, Wang C, Gunaratne J, Bahl J, Ong EZ, et al. Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness. Science. 2015; 350(6257): 217-21.
96. Kakumani PK, Ponia SS, RK S, Sood V, Chinnappan M, Banerjea AC, et al. Role of RNA interference (RNAi) in dengue virus replication and identification of NS4B as an RNAi suppressor. J Virol. 2013; 87(16): 8870-83.
97. Scott JC, Brackney DE, Campbell CL, Bondu-Hawkins V, Hjelle B, Ebel GD, et al. Comparison of dengue virus type 2-specific small RNAs from RNA interference-competent and-incompetent mosquito cells. PLoS Negl Trop Dis. 2010; 4(10): e848.
98. Hess AM, Prasad AN, Ptitsyn A, Ebel GD, Olson KE, Barbacioru C, et al. Small RNA profiling of dengue virus-mosquito interactions implicates the PIWI RNA pathway in anti-viral defense. BMC Microbiol. 2011; 11: 45.
99. Schirtzinger EE, Andrade CC, Devitt N, Ramaraj T, Jacobi JL, Schilkey F, et al. Repertoire of virus-derived small RNAs produced by mosquito and mammalian cells in response to dengue virus infection. Virology. 2015; 476: 54-60.
100. Bogerd HP, Skalsky RL, Kennedy EM, Furuse Y, Whisnant AW, Flores O, et al. Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs. J Virol. 2014; 88(14): 8065-76.
101. Ospina-Bedoya M, Campillo-Pedroza N, Franco-Salazar JP, Gallego-Gomez JC. Computational Identification of dengue virus microRNA-Like Structures and their Cellular Targets. Bioinform Biol Insights. 2014; 8: 169-76.
102. van den Hurk AF, Ritchie SA, Mackenzie JS. Ecology and geographical expansion of Japanese encephalitis virus. Annu Rev Entomol. 2009; 54: 17-35.
103. Fan YH, Nadar M, Chen CC, Weng CC, Lin YT, Chang RY. Small noncoding RNA modulates Japanese encephalitis virus replication and translation in trans. Virol J. 2011; 8: 492.
104. Chang RY, Hsu TW, Chen YL, Liu SF, Tsai YJ, Lin YT, et al. Japanese encephalitis virus non-coding RNA inhibits activation of interferon by blocking nuclear translocation of interferon regulatory factor 3. Vet Microbiol. 2013; 166(1-2): 11-21.
105. Knox J, Cowan RU, Doyle JS, Ligtermoet MK, Archer JS, Burrow JN, et al. Murray Valley encephalitis: A review of clinical features, diagnosis and treatment. Med J Aust. 2012; 196(5): 322-6.
106. Selvey L.A, Dailey L., Lindsay M., Armstrong P., Tobin S., Koehler A.P.,Markey P.G.,Smith D.W.The Changing Epidemiology of Murray Valley Encephalitis in Australia: The 2011 Outbreak and a Review of the Literature.PLoS Neglected Tropical Diseases 8(1),2014
107. Tomori O. Yellow fever: the recurring plague. Crit Rev Clin Lab Sci. 2004; 41(4): 391-427.
108. Barnett ED. Yellow fever: epidemiology and prevention. Clin Infect Dis. 2007; 44(6): 850-6.
109. Silva PA, Pereira CF, Dalebout TJ, Spaan WJ, Bredenbeek PJ. An RNA pseudoknot is required for production of yellow fever virus subgenomic RNA by the host nuclease XRN1. J Virol. 2010; 84(21): 11395-406.
110. Silva PAGC. Functions and requirements of conserved RNA structures in the 3 untranslated region of Flaviviruses. Netherlands: Leiden University Medical Center (LUMC); 2011.
111. Villordo SM, Carballeda JM, Filomatori CV, Gamarnik AV. RNA structure duplications and flavivirus host adaptation. Trends Microbiol. 2016; 24(4): 270-83.
112. Schnettler E, Tykalová H, Watson M, Sharma M, Sterken MG, Obbard DJ, et al. Induction and suppression of tick cell antiviral RNAi responses by tick-borne flaviviruses. Nucleic Acids Res. 2014; 42(14): 9436-46.
113. Li SC, Shiau CK, Lin WC. Vir-Mir db: prediction of viral microRNA candidate hairpins. Nucleic Acids Res. 2008; 36(Database issue): D184-9.
114. Vir-Mir database. http://alk. ibms. sinica. edu. Tw/cgi-bin/miRNA/virus-tax. cgitax-id=35278. Accessed 29 Mar 2015.
115. Brackney DE, Beane JE, Ebel GD. RNAi targeting of West Nile virus in mosquito midguts promotes virus diversification. PLoS Pathog. 2009; 5(7): e1000502.
116. Bryant JE, Vasconcelos PF, Rijnbrand RC, Mutebi JP, Higgs S, Barrett AD. Size heterogeneity in the 3 noncoding region of South American isolates of yellow fever virus. J Virol. 2005; 79(6): 3807-21.
117. Ho BC, Yu IS, Lu LF, Rudensky A, Chen HY, Tsai CW, et al. Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat Commun. 2014; 5: 3344.
118. Wu S, He L, Li Y, Wang T, Feng L, Jiang L, et al. miR-146a facilitates replication of dengue virus by dampening interferon induction by targeting TRAF6. J Infect. 2013; 67(4): 329-41.
119. Umbach JL, Cullen BR. The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev. 2009; 23(10): 1151-64.
120. Smith JL, Grey FE, Uhrlaub JL, Nikolich-Zugich J, Hirsch AJ. Induction of the cellular microRNA, Hs-154, by West Nile virus contributes to virus-mediated apoptosis through repression of antiapoptotic factors. J Virol. 2012; 86(9): 5278-87.
121. Slonchak A, Shannon RP, Pali G, Khromykh AA. Human miRNA miR-532-5p exhibits antiviral activity against West Nile virus via suppression of host genes SESTD1 and TAB3 required for virus replication. J Virol. 2015; 90(5): 2388-402.
122. Kumar M, Nerurkar VR. Integrated analysis of microRNAs and their disease related targets in the brain of mice infected with West Nile virus. Virology. 2014; 452-453: 143-51.
123. Zhu X, He Z, Hu Y, Wen W, Lin C, Yu J, et al. MicroRNA-30e suppresses dengue virus replication by promoting NF-kappaB-dependent IFN production. PLoS Negl Trop Dis. 2014; 8(8): e3088.
124. Escalera-Cueto M, Medina-Martinez I, del Angel RM, Berumen-Campos J, Gutierrez-Escolano AL, Yocupicio-Monroy M. Let-7c overexpression inhibits dengue virus replication in human hepatoma Huh-7 cells. Virus Res. 2015; 196: 105-12.
125. Qi Y, Li Y, Zhang L, Huang J. microRNA expression profiling and bioinformatic analysis of dengue virus-infected peripheral blood mononuclear cells. Mol Med Rep. 2013; 7(3): 791-8.
126. Chen RF, Yang KD, Lee IK, Liu JW, Huang CH, Lin CY, et al. Augmented miR-150 expression associated with depressed SOCS1 expression involved in dengue haemorrhagic fever. J Infect. 2014; 69(4): 366-74.
127. Wu N, Gao N, Fan D, Wei J, Zhang J, An J. miR-223 inhibits dengue virus replication by negatively regulating the microtubule-destabilizing protein STMN1 in EAhy926 cells. Microbes Infect. 2014; 16(11): 911-22.
128. Tambyah PA, Ching CS, Sepramaniam S, Ali JM, Armugam A, Jeyaseelan K. microRNA expression in blood of dengue patients. Ann Clin Biochem. 2015, [Epub ahead of print].
129. Zhu B, Ye J, Nie Y, Ashraf U, Zohaib A, Duan X, et al. MicroRNA-15b Modulates Japanese Encephalitis Virus-Mediated Inflammation via Targeting RNF125. J Immunol. 2015; 195(5): 2251-62.
130. Thounaojam MC, Kaushik DK, Kundu K, Basu A. MicroRNA-29b modulates Japanese encephalitis virus-induced microglia activation by targeting tumor necrosis factor alpha-induced protein 3. J Neurochem. 2014; 129(1): 143-54.
131. Thounaojam MC, Kundu K, Kaushik DK, Swaroop S, Mahadevan A, Shankar SK, et al. MicroRNA 155 regulates Japanese encephalitis virus-induced inflammatory response by targeting Src homology 2-containing inositol phosphatase 1. J Virol. 2014; 88(9): 4798-810.
132. Pareek S, Roy S, Kumari B, Jain P, Banerjee A, Vrati S. MiR-155 induction in microglial cells suppresses Japanese encephalitis virus replication and negatively modulates innate immune responses. J Neuroinflammation. 2014; 11: 97.
133. Sharma N, Verma R, Kumawat KL, Basu A, Singh SK. miR-146a suppresses cellular immune response during Japanese encephalitis virus JaOArS982 strain infection in human microglial cells. J Neuroinflammation. 2015; 12(1): 30.
134. Cai Y, Zhu L, Zhou Y, Liu X, Li X, Lang Q, et al. Identification and analysis of differentially-expressed microRNAs in Japanese encephalitis virus-infected PK-15 cells with deep sequencing. Int J Mol Sci. 2015; 16(1): 2204-19.
135. Hou J, Wang P, Lin L, Liu X, Ma F, An H, et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol. 2009; 183(3): 2150-8.
136. Stewart CR, Marsh GA, Jenkins KA, Gantier MP, Tizard ML, Middleton D, et al. Promotion of Hendra virus replication by microRNA 146a. J Virol. 2013; 87(7): 3782-91.
137. Wang S, Zhang X, Ju Y, Zhao B, Yan X, Hu J, et al. MicroRNA-146a feedback suppresses T cell immune function by targeting Stat1 in patients with chronic hepatitis B. J Immunol. 2013; 191(1): 293-301.
138. Li JF, Dai XP, Zhang W, Sun SH, Zeng Y, Zhao GY, et al. Upregulation of MicroRNA-146a by Hepatitis B Virus X Protein Contributes to Hepatitis Development by Downregulating Complement Factor H. MBio. 2015; 6(2) doi: 10. 1128/mBio. 02459-14.
139. Hill JM, Clement C, Zhao Y, Lukiw WJ. Induction of the pro-inflammatory NF-kB-sensitive miRNA-146a by human neurotrophic viruses. Front Microbiol. 2015; 6: 43.
140. Li L, Chen XP, Li YJ. MicroRNA-146a and human disease. Scand J Immunol. 2010; 71(4): 227-31.